<DOC>
	<DOCNO>NCT02832635</DOCNO>
	<brief_summary>The purpose study evaluate effect neurocognitive function whole-brain radiotherapy ( WBRT ) with/without TMZ concurrent chemotherapy avoidance hippocampus patient brain metastasis , well feasibility risk avoidance hippocampus whole-brain radiotherapy .</brief_summary>
	<brief_title>A Clinical Trial Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy Avoidance Hippocampus Patients Brain Metastases</brief_title>
	<detailed_description>This phase II randomize clinical trial . It report avoidance hippocampus whole-brain radiotherapy ( WBRT ) benefit preservation memory patient , use concurrent TMZ radiotherapy patient brain metastasis benefit treat outcome . The purpose study evaluate effect neurocognitive function whole-brain radiotherapy with/without TMZ concurrent chemotherapy avoidance hippocampus patient brain metastasis , well feasibility risk avoidance hippocampus whole-brain radiotherapy .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<criteria>Primary lesion diagnose pathology cytology Brain metastasis confirm brain MRI CT ( ＞3 brain metastases） Brain metastases beyond 5mm hippocampus Male female patient age 18 75 year old Karnofsky Performance Scores ≥ 60 Expected survival ≥ 6 month No previous brain surgery brain radiotherapy Without dysfunction heart , lung , liver , kidney hematopoiesis The primary carcinoma control MMSE score ＜27 Dysfunction heart , lung , liver , kidney hematopoiesis Severe neurological , mental endocrine diseases History alcohol drug abuse within 3 month Visual hearing dysfunction , low education level , reason lead capable take MMSE test Currently treatment may effect patient ' neurocognitive function Patients participate clinical trial drug within last 3 month Other unsuitable reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>brain metastasis</keyword>
	<keyword>whole-brain radiotherapy</keyword>
	<keyword>TMZ</keyword>
	<keyword>avoidance hippocampus</keyword>
</DOC>